Post a Comment Print Share on Facebook
Featured top 700 best universities Motoring KAZAKHSTAN UNIVERSITIES United Nations Peacekeeping Why is it so cold


EU to purchase 200M extra doses of BioNTech vaccine

BioNTech has announced Wednesday that the European Union will buy an additional 200 million doses of coronavirus vaccine from the company, and these are planned to be delivered throughout this year. 

Dr. Ugur Sahin, the co-founder of BioNTech, said they have taken additional steps together with their American partner Pfizer to significantly boost their production capacity in Europe.

“We will initiate production at our Marburg facility this month and have strengthened our manufacturing network with additional partners. We are continuing to evaluate, together with governments, authorities, and partners at all levels, how we might address an even higher future supply requirement for our vaccines,” he said. 

BioNTech/Pfizer’s new agreement with Brussels brings total supply to the EU to 500 million doses, with an option for an additional 100 million doses.

The new manufacturing site of BioNTech in Marburg, Germany has an annual production capacity of up to 750 million doses of coronavirus vaccine. 

BioNTech/Pfizer’s mRNA-based vaccine, known as COMIRNATY, was the first coronavirus vaccine approved for use in the European Union. It also received emergency use or conditional marketing authorization in more than 45 countries, including the UK, Canada, and the US.

Your Name
Post a Comment
Characters Left:
Your comment has been forwarded to the administrator for approval.×
Warning! Will constitute a criminal offense, illegal, threatening, offensive, insulting and swearing, derogatory, defamatory, vulgar, pornographic, indecent, personality rights, damaging or similar nature in the nature of all kinds of financial content, legal, criminal and administrative responsibility for the content of the sender member / members are belong.